Kevin F McLaughlin's Net Worth

$23.6 Million

Estimate Recalculated Nov 1, 2024 10:01AM EST

Who is Kevin F McLaughlin

Kevin F McLaughlin has an estimated net worth of $23.6 Million. This is based on reported shares across multiple companies, which include Vericel Corp, Decibel Therapeutics, Inc., ACCELERON PHARMA INC, PRAECIS PHARMACEUTICALS INC, and Invivyd, Inc..

SEC CIK

Kevin F McLaughlin's CIK is 0001214938

Past Insider Trading and Trends

2015 was Kevin F McLaughlin's most active year for acquiring shares with 25 total transactions. Kevin F McLaughlin's most active month to acquire stocks was the month of November. 2015 was Kevin F McLaughlin's most active year for disposing of shares, totalling 59 transactions. Kevin F McLaughlin's most active month to dispose stocks was the month of November. 2020 saw Kevin F McLaughlin paying a total of $3,573,047.72 for 151,328 shares, this is the most they've acquired in one year. In 2020 Kevin F McLaughlin cashed out on 215,329 shares for a total of $11,450,947.89, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vericel Corp

Investor
Updated Aug 09, 2024
Form 4
39.11%
7.00K
$24.84
-$295.40K
Aug 09, 2024
24.90K
Sell-Options
Aug 07
Form 4
320.00%
17.60K
May 03, 2024
23.10K
Options
May 01
Form 4
11.20K
May 05, 2023
11.20K
Grant
May 03
Form 4
Apr 28, 2023
8.70K
Options
Apr 27
Form 4
149.18%
9.10K
Apr 29, 2022
15.20K
Options
Apr 27
Form 4
260.00%
9.10K
Apr 30, 2021
12.60K
Options
Apr 28
Form 4
850.00%
14.88K
$14.56
-$25.48K
May 01, 2020
16.63K
Options
Apr 29
Form 4
14.88K
May 03, 2019
14.88K
Grant
May 01
Form 4
17.50K
May 03, 2018
17.50K
Grant
May 02
Form 4
17.50K
May 05, 2017
17.50K
Grant
May 03
Form 4
15.00K
May 06, 2016
15.00K
Grant
May 04
Form 3/A
Aug 28, 2015
Form 4
20.00K
Mar 24, 2015
20.00K
Grant
Mar 20
Form 3
Jan 07, 2015
Showing 14 results

Decibel Therapeutics, Inc.

Investor
Updated Sep 25, 2023
Form 4
-100.00%
-30.00K
Sep 25, 2023
Disposition
Sep 25
Form 4
10.00K
Jun 14, 2023
10.00K
Grant
Jun 13
Form 4
20.00K
Oct 12, 2022
20.00K
Grant
Oct 10
Form 3
Oct 12, 2022
Showing 4 results

ACCELERON PHARMA INC

SVP, CFO and Treasurer
Updated Nov 22, 2021
Form 4
-100.00%
-88.25K
Nov 22, 2021
Disposition
Nov 19
Form 4
-35.66%
-25.00K
$100.11
-$3.01M
Sep 24, 2021
45.11K
Sale
ScheduledSep 23 - Sep 24
Form 4
407.26%
23.67K
Feb 02, 2021
29.49K
Grant
Jan 29
Form 4
-48.17%
-5.40K
$123.37
-$666.54K
Jan 06, 2021
5.81K
Sale
ScheduledJan 04 - Jan 05
Form 4
-49.93%
-42.53K
$81.21
-$4.16M
Dec 15, 2020
42.64K
Sale
ScheduledDec 14
Form 4
-8.07%
-7.47K
$81.65
-$648.13K
Dec 11, 2020
85.17K
Sale
ScheduledDec 09 - Dec 11
Form 4
-46.63%
-54.00K
$60.91
-$2.75M
Apr 10, 2020
61.82K
Sale
ScheduledApr 08 - Apr 09
Form 4
633.44%
30.70K
Jan 24, 2020
35.55K
Grant
Jan 22
Form 4
-53.51%
-5.58K
$52.50
-$292.92K
Jan 03, 2020
4.85K
Sale
ScheduledJan 02
Form 4
-53.20%
-11.85K
$50.28
-$595.97K
Dec 17, 2019
10.43K
Sale
ScheduledDec 13
Form 4
-26.42%
-8.00K
$45.30
-$362.40K
Sep 10, 2019
22.28K
Sale
ScheduledSep 10
Form 4
-28.38%
-12.00K
$44.62
-$535.40K
Apr 11, 2019
30.28K
Sale
ScheduledApr 09
Form 4
-1.51%
-648.00
$48.02
-$31.12K
Apr 04, 2019
42.28K
Sale
ScheduledApr 02
Form 4
85.54%
32.70K
Jan 29, 2019
70.93K
Grant
Jan 25
Form 4
-13.00%
-5.71K
$42.80
-$244.49K
Jan 04, 2019
38.23K
Sale
ScheduledJan 02
Form 4
-16.72%
-12.50K
$40.99
-$325.37K
Aug 31, 2018
62.24K
Sale
ScheduledAug 30
Form 4
-34.28%
-25.00K
$36.06
-$597.25K
Jul 03, 2018
47.94K
Sale
ScheduledJun 29
Form 4
-8.34%
-4.00K
$38.45
-$153.79K
Apr 04, 2018
43.94K
Sale
ScheduledApr 03
Form 4
84.02%
35.96K
Mar 05, 2018
78.76K
Grant
Mar 01
Form 4
-30.74%
-19.00K
$23.74
-$757.59K
Jan 04, 2018
42.80K
Sale
ScheduledJan 02 - Jan 04
Form 4
-24.50%
-16.00K
$38.41
-$614.55K
Sep 14, 2017
49.30K
Sale
ScheduledSep 12
Form 4
-32.47%
-34.40K
$19.43
-$950.67K
Jul 07, 2017
71.55K
Sale
ScheduledJul 05
Form 4
67.98%
48.20K
Mar 14, 2017
119.10K
Grant
Mar 02
Form 4
-2.34%
-1.70K
$27.45
-$46.67K
Jan 06, 2017
70.90K
Sale
ScheduledJan 04
Form 4
$3.88
$38.80K
Jan 04, 2017
78.85K
Options
Jan 03
Form 4
$3.88
$19.40K
Jul 07, 2016
78.85K
Options
Jul 07
Form 4
-27.41%
-25.30K
$19.97
-$796.11K
Jul 06, 2016
67.00K
Sale
ScheduledJul 01
Form 4
-21.51%
-25.30K
$19.64
-$858.62K
May 25, 2016
92.30K
Sale
ScheduledMay 23
Form 4
41.03%
35.90K
Mar 07, 2016
123.40K
Grant
Mar 03
Form 4
$3.88
$29.10K
Dec 23, 2015
108.75K
Options
Dec 22
Form 4
-6.05%
-7.00K
$14.13
-$143.48K
Oct 09, 2015
108.75K
Sale
ScheduledOct 07
Form 4
100.00%
40.00K
Sep 11, 2015
80.00K
Grant
Sep 09
Form 4
-7.90%
-6.50K
$17.02
-$170.80K
Sep 10, 2015
75.75K
Sale
ScheduledSep 08
Form 4
-7.32%
-6.50K
$16.21
-$160.21K
Aug 12, 2015
82.25K
Sale
ScheduledAug 10
Form 4
$3.88
$19.40K
Jul 30, 2015
88.75K
Options
Jul 28
Form 4
-7.31%
-7.00K
$16.79
-$180.75K
Jul 09, 2015
88.75K
Sale
ScheduledJul 07
Form 4
$3.88
$19.40K
Jun 10, 2015
95.75K
Options
Jun 10
Form 4
-6.36%
-6.50K
$18.19
-$185.95K
Jun 09, 2015
95.75K
Sale
ScheduledJun 08
Form 4
-5.98%
-6.50K
$17.84
-$162.06K
May 13, 2015
102.25K
Sale
ScheduledMay 11
Form 4
-6.05%
-7.00K
$19.38
-$217.00K
Apr 08, 2015
108.75K
Sale
ScheduledApr 07
Form 4
-5.32%
-6.50K
$22.07
-$236.43K
Mar 10, 2015
115.75K
Sale
ScheduledMar 09
Form 4
-5.05%
-6.50K
$20.26
-$212.96K
Feb 11, 2015
122.25K
Sale
ScheduledFeb 09
Form 4
-1.53%
-2.00K
$22.27
-$73.56K
Jan 13, 2015
128.75K
Sale
ScheduledJan 12
Form 4
26.52%
36.00K
$21.67
-$177.91K
Jan 09, 2015
171.75K
Sell-Options
ScheduledJan 07 - Jan 08
Form 4
$3.88
$58.20K
Dec 19, 2014
135.75K
Options
Dec 19
Form 4
-6.86%
-10.00K
$23.95
-$401.44K
Dec 09, 2014
135.75K
Sale
ScheduledDec 08
Form 4
-6.42%
-10.00K
$18.51
-$292.62K
Nov 14, 2014
145.75K
Sale
ScheduledNov 12
Form 4
$3.88
$38.80K
Oct 27, 2014
155.75K
Options
Oct 27
Form 4
-6.03%
-10.00K
$16.57
-$253.70K
Oct 09, 2014
155.75K
Sale
ScheduledOct 07
Form 4
-5.69%
-10.00K
$14.18
-$205.97K
Sep 10, 2014
165.75K
Sale
ScheduledSep 08 - Sep 09
Form 4
-5.38%
-10.00K
$16.83
-$259.01K
Aug 15, 2014
175.75K
Sale
ScheduledAug 14
Form 4
-5.11%
-10.00K
$17.80
-$278.37K
Jul 09, 2014
185.75K
Sale
ScheduledJul 07
Form 4
-4.86%
-10.00K
$17.77
-$277.67K
Jun 11, 2014
195.75K
Sale
ScheduledJun 09
Form 4
-4.63%
-10.00K
$17.70
-$276.34K
May 21, 2014
205.75K
Sale
ScheduledMay 19
Form 4
29.00K
Dec 09, 2013
29.00K
Grant
Dec 05
Form 3
Sep 18, 2013
Showing 56 results

PRAECIS PHARMACEUTICALS INC

President and CEO
Updated Feb 08, 2007
Form 4
-100.00%
-125.00K
$3.33
-$357.00K
Feb 08, 2007
Disposition
Feb 07 - Feb 08
Form 4
$1.33
$32.19K
Sep 05, 2006
45.00K
Options
Sep 01
Form 4
400.00K
Jun 01, 2005
504.00K
Grant
May 27
Form 4
108.00K
Nov 15, 2004
212.00K
Grant
Nov 11
Form 4
50.00K
Sep 17, 2004
154.00K
Grant
Sep 16
Form 4
$0.27
$2.70K
Feb 09, 2004
225.00K
Options
Feb 06
Form 4
$0.27
$540.00
Dec 30, 2003
225.00K
Options
Dec 30
Form 4
-9.04%
-35.00K
$3.88
-$255.25K
Dec 03, 2003
352.00K
Sale
Dec 02
Form 4
87.50K
Nov 14, 2003
189.50K
Grant
Nov 13
Showing 9 results

Invivyd, Inc.

Investor
Updated May 23, 2024
Form 4
100.00K
May 23, 2024
100.00K
Grant
May 21
Form 3
May 23, 2024
Showing 2 results